Thanks to Ray Simpson for sharing this FDA Bulletin with OKAMA!

Due to the ongoing critical shortages of injectable drugs used in critical care, FDA is alerting health care professionals and emergency responders of updated dates through which some of these injectable drugs, manufactured by Hospira Inc, a Pfizer company, may be used beyond the manufacturer’s labeled expiration date. To help ensure patient safety, these products should have been — and should continue to be — stored as per labeled conditions.

Hospitals that have the following lot numbers in stock will be able to use them through the corresponding new use dates to help with supply. As data on additional emergency syringe products and lot numbers become available, this list can be expanded.

Further information is found here. Please contact CDER Drug Shortage Staff at drugshortages@fda.hhs.gov with questions regarding these tables.